Lead Edge Capital, a technology-focused investment fund, agreed to invest in PaceMate, a cardiac data management platform. Financial terms were not disclosed. “PaceMate delivers a powerful set of solutions focused on improving patient care and outcomes within the cardiac disease segment. Over the past several years, the company has worked tirelessly to deliver superior technology, service, and a level of care which has been unparalleled within the market. We are thrilled to partner with Tripp and the team on PaceMate’s next phase of growth,” Brian Neider, Lead Edge Capital Partner.